BioPharmGuy logo
BioPharmGuy Database
Emery Pharma
Bioverativ is defunct.

Acquired by Sanofi, Jan 2018, $11.6B; Biogen's spinout hemophilia group


------------------
If you believe any of this information is incorrect, please let us know.